Výsledky vyhledávání - "on behalf of the AIRFLOW-3 Trial Study Group"

Akademický článek

Design for a multicenter, randomized, sham-controlled study to evaluate safety and efficacy after treatment with the Nuvaira® lung denervation system in subjects with chronic obstructive pulmonary disease (AIRFLOW-3)

Autor: Dirk-Jan Slebos, Bruno Degano, Arschang Valipour, Pallav L. Shah, Gaetan Deslée, Frank C. Sciurba, on behalf of the AIRFLOW-3 Trial Study Group

Publikováno v: BMC Pulmonary Medicine, Vol 20, Iss 1, Pp 1-10 (2020)

Abstract Background Targeted lung denervation (TLD) is a bronchoscopically delivered ablation therapy that selectively interrupts pulmonary parasympathetic nerve signaling. The procedure has the potential to alter airway smooth muscle tone and reacti

Externí odkaz: https://doaj.org/article/076f3c7499fe42e2bd3163b626afe54c

Zobrazit plný text záznamu

Design for a multicenter, randomized, sham-controlled study to evaluate safety and efficacy after treatment with the Nuvaira (R) lung denervation system in subjects with chronic obstructive pulmonary disease (AIRFLOW-3)

Autor: Dirk-Jan Slebos, Bruno Degano, Arschang Valipour, Pallav L. Shah, Gaetan Deslée, Frank C. Sciurba, on behalf of the AIRFLOW-3 Trial Study Group

Publikováno v: BMC Pulmonary Medicine
BMC Pulmonary Medicine, BioMed Central, 2020, 20 (1), ⟨10.1186/s12890-020-1058-5⟩
BMC Pulmonary Medicine, 20(1):41. BioMed Central Ltd.
BMC Pulmonary Medicine, Vol 20, Iss 1, Pp 1-10 (2020)

Background Targeted lung denervation (TLD) is a bronchoscopically delivered ablation therapy that selectively interrupts pulmonary parasympathetic nerve signaling. The procedure has the potential to alter airway smooth muscle tone and reactivity, dec

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::074096a1887455789467d05ffad6c957
http://hdl.handle.net/10044/1/78005

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání